Importer of Controlled Substances Application: United States Pharmacopeial Convention, 21887-21888 [2020-08269]
Download as PDF
<![CDATA[
21887
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection
(check justification or form 83):
Revision of a currently approved
collection.
2. The Title of the Form/Collection:
ATF Adjunct Instructor Data Form.
3. The agency form number, if any,
and the applicable component of the
Department sponsoring the collection:
Form number (if applicable): ATF
Form 6140.3.
Component: Bureau of Alcohol,
Tobacco, Firearms and Explosives, U.S.
Department of Justice.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Federal Government.
Other (if applicable): Individuals or
households, Business or other for-profit,
Not-for-profit institutions, and State,
Local or Tribal Government.
Abstract: The Adjunct Instructor Data
Form—ATF Form 6140.3 will be used to
collect the necessary personally
identifiable information (PII) from nonATF employees, in order to document
and evaluate their qualifications to serve
as an ATF instructor.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: An estimated 20 respondents
will utilize the form annually, and it
will take each respondent
approximately 30 minutes to complete
their responses.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated annual public
burden associated with this collection is
10 hours, which is equal to 20 (# of
respondents) * 1 (# of responses per
respondent) * .5 (30 minutes).
If additional information is required
contact: Melody Braswell, Department
Clearance Officer, United States
Department of Justice, Justice
Management Division, Policy and
Planning Staff, Two Constitution
Square, 145 N Street NE, 3E.405A,
Washington, DC 20530.
Dated: April 15, 2020.
Melody Braswell,
Department Clearance Officer for PRA, U.S.
Department of Justice.
[FR Doc. 2020–08251 Filed 4–17–20; 8:45 am]
BILLING CODE 4410–14–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–617]
Importer of Controlled Substances
Application: United States
Pharmacopeial Convention
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 20, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 20, 2020.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on March 4, 2020, United
States Pharmacopeial Convention,
12601 Twinbrook Parkway, Rockville,
Maryland 20852, applied to be
registered as an importer of the
following basic class(es) of controlled
substances:
DATES:
jbell on DSKJLSW7X2PROD with NOTICES
Controlled substance
Drug code
Methamphetamine ...........................................................................................................................................................
Cathinone ........................................................................................................................................................................
Phenmetrazine .................................................................................................................................................................
Methylphenidate ..............................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Pentobarbital ....................................................................................................................................................................
Secobarbital .....................................................................................................................................................................
Glutethimide .....................................................................................................................................................................
Methaqualone ..................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine .............................................................................................................................
3,4-Methylenedioxyamphetamine ....................................................................................................................................
4-Methoxyamphetamine ..................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
ANPP (4-Anilino-N-phenethyl-4-piperidine) .....................................................................................................................
Phenylacetone .................................................................................................................................................................
Alphaprodine ....................................................................................................................................................................
Anileridine ........................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
VerDate Sep<11>2014
18:34 Apr 17, 2020
Jkt 250001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4703
E:\FR\FM\20APN1.SGM
20APN1
1105
1235
1631
1724
2125
2270
2315
2550
2565
7315
7395
7400
7411
7471
8333
8501
9010
9020
9041
9053
Schedule
II
I
II
II
II
II
II
II
I
I
I
I
I
II
II
II
II
II
II
I
21888
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
Controlled substance
Drug code
Dihydrocodeine ................................................................................................................................................................
Difenoxin ..........................................................................................................................................................................
Diphenoxylate ..................................................................................................................................................................
Heroin ..............................................................................................................................................................................
Levomethorphan ..............................................................................................................................................................
Levorphanol .....................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine-N-oxide ............................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Norlevorphanol ................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Noroxymorphone .............................................................................................................................................................
Alfentanil ..........................................................................................................................................................................
Sufentanil .........................................................................................................................................................................
The company plans to import the bulk
control substances for distribution of
analytical reference standards to its
customers for analytical testing of raw
materials.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020–08269 Filed 4–17–20; 8:45 am]
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before May 20, 2020. Such persons
may also file a written request for a
hearing on the application on or before
May 20, 2020.
DATES:
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All request for a hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
ADDRESSES:
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–624]
Importer of Controlled Substances
Application: VHG Labs DBA LGC
Standards
ACTION:
Notice of application.
In
accordance with 21 CFR 1301.34(a), this
is notice that on March 12, 2020, VHG
Labs DBA LGC Standards, 3 Perimeter
Road, Manchester, New Hampshire
03103, applied to be registered as an
importer of the following basic class(es)
of controlled substances:
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
Drug code
Cathinone ........................................................................................................................................................................
Methcathinone .................................................................................................................................................................
Naphyrone .......................................................................................................................................................................
N-Ethylamphetamine .......................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..................................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ................................................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide ..............................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..................................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ....................................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ..............................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .....................................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ......................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Marihuana Extract ...........................................................................................................................................................
Marihuana ........................................................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Mescaline .........................................................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ......................................................................................................
3,4-Methylenedioxymethamphetamine ............................................................................................................................
5-Methoxy-N-N-dimethyltryptamine .................................................................................................................................
Psilocyn ...........................................................................................................................................................................
4-Methyl-alphapyrrolidinopropiophenone (4-MePPP) .....................................................................................................
MDPV (3,4-Methylenedioxypyrovalerone) .......................................................................................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ......................................................................................................
Butylone ...........................................................................................................................................................................
Pentylone .........................................................................................................................................................................
Codeine-N-oxide ..............................................................................................................................................................
18:34 Apr 17, 2020
Jkt 250001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
II
I
II
I
II
II
II
II
I
II
I
II
II
II
II
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Controlled substance
VerDate Sep<11>2014
9120
9168
9170
9200
9210
9220
9230
9273
9307
9333
9634
9652
9668
9737
9740
Schedule
E:\FR\FM\20APN1.SGM
20APN1
1235
1237
1258
1475
6250
7008
7048
7081
7104
7118
7122
7144
7203
7260
7315
7350
7360
7370
7381
7398
7405
7431
7438
7498
7535
7540
7541
7542
9053
Schedule
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
]]>Agencies
[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Pages 21887-21888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08269]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-617]
Importer of Controlled Substances Application: United States
Pharmacopeial Convention
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before May 20, 2020.
Such persons may also file a written request for a hearing on the
application on or before May 20, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a
hearing must be sent to: Drug Enforcement Administration, Attn:
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All
request for a hearing should also be sent to: (1) Drug Enforcement
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive,
Springfield, Virginia 22152; and (2) Drug Enforcement Administration,
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive,
Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this
is notice that on March 4, 2020, United States Pharmacopeial
Convention, 12601 Twinbrook Parkway, Rockville, Maryland 20852, applied
to be registered as an importer of the following basic class(es) of
controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Methamphetamine.......................... 1105 II
Cathinone................................ 1235 I
Phenmetrazine............................ 1631 II
Methylphenidate.......................... 1724 II
Amobarbital.............................. 2125 II
Pentobarbital............................ 2270 II
Secobarbital............................. 2315 II
Glutethimide............................. 2550 II
Methaqualone............................. 2565 I
Lysergic acid diethylamide............... 7315 I
4-Methyl-2,5-dimethoxyamphetamine........ 7395 I
3,4-Methylenedioxyamphetamine............ 7400 I
4-Methoxyamphetamine..................... 7411 I
Phencyclidine............................ 7471 II
ANPP (4-Anilino-N-phenethyl-4-piperidine) 8333 II
Phenylacetone............................ 8501 II
Alphaprodine............................. 9010 II
Anileridine.............................. 9020 II
Cocaine.................................. 9041 II
Codeine-N-oxide.......................... 9053 I
[[Page 21888]]
Dihydrocodeine........................... 9120 II
Difenoxin................................ 9168 I
Diphenoxylate............................ 9170 II
Heroin................................... 9200 I
Levomethorphan........................... 9210 II
Levorphanol.............................. 9220 II
Meperidine............................... 9230 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine-N-oxide......................... 9307 I
Thebaine................................. 9333 II
Norlevorphanol........................... 9634 I
Oxymorphone.............................. 9652 II
Noroxymorphone........................... 9668 II
Alfentanil............................... 9737 II
Sufentanil............................... 9740 II
------------------------------------------------------------------------
The company plans to import the bulk control substances for
distribution of analytical reference standards to its customers for
analytical testing of raw materials.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-08269 Filed 4-17-20; 8:45 am]
BILLING CODE 4410-09-P
